{"id":824,"date":"2022-02-18T08:28:34","date_gmt":"2022-02-18T13:28:34","guid":{"rendered":"https:\/\/herpescureadvocacy.com\/?p=824"},"modified":"2022-02-18T09:03:46","modified_gmt":"2022-02-18T14:03:46","slug":"moderna-adds-herpes-vaccine-candidate-to-pipeline","status":"publish","type":"post","link":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/","title":{"rendered":"Moderna Adds Herpes Vaccine Candidate to Pipeline"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-full is-resized\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" data-attachment-id=\"825\" data-permalink=\"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/pexels-photo-2280547\/\" data-orig-file=\"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg?fit=868%2C1300&amp;ssl=1\" data-orig-size=\"868,1300\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"shallow focus photography of microscope\" data-image-description=\"\" data-image-caption=\"&lt;p&gt;Photo by Chokniti Khongchum on &lt;a href=&quot;https:\/\/www.pexels.com\/photo\/shallow-focus-photography-of-microscope-2280547\/&quot; rel=&quot;nofollow&quot;&gt;Pexels.com&lt;\/a&gt;&lt;\/p&gt;\n\" data-large-file=\"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg?fit=684%2C1024&amp;ssl=1\" src=\"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg?resize=477%2C714&#038;ssl=1\" alt=\"\" class=\"wp-image-825\" width=\"477\" height=\"714\" \/><\/figure><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Moderna is entering the global race for a Herpes vaccine. Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines.\u00a0 They are best known for recent success with their mRNA-based COVID-19 vaccine. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">From Moderna website: <em>Moderna&#8217;s herpes simplex virus (HSV) vaccine candidate (mRNA-1608) is a vaccine candidate against HSV-2 disease. Moderna expects that an HSV-2 vaccine could provide cross-protection against HSV-1. With mRNA-1608, the Company aims to induce strong antibody response with neutralizing and effector functionality combined with cell-mediated immunity. There is no vaccine approved against HSV.<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">More details on the Moderna website <a href=\"https:\/\/www.accesswire.com\/689417\/Moderna-Expands-Its-mRNA-Pipeline-with-Three-New-Development-Programs\">here<\/a>. <\/p>\n\n\n\n<hr class=\"wp-block-separator\" \/>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"get-in-touch\"><strong>Get<\/strong> in Touch<\/h2>\n\n\n","protected":false},"excerpt":{"rendered":"<p>Moderna is entering the global race for a Herpes vaccine. Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines.\u00a0<a class=\"more-link\" href=\"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/\">Continue reading <span class=\"screen-reader-text\">&#8220;Moderna Adds Herpes Vaccine Candidate to Pipeline&#8221;<\/span><\/a><\/p>\n","protected":false},"author":205069572,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"{title}\n\n{excerpt}\n\n{url}","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"_wpas_customize_per_network":false,"jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-824","post","type-post","status-publish","format-standard","hentry","category-uncategorized","entry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Moderna Adds Herpes Vaccine Candidate to Pipeline - Herpes Cure Advocacy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Moderna Adds Herpes Vaccine Candidate to Pipeline - Herpes Cure Advocacy\" \/>\n<meta property=\"og:description\" content=\"Moderna is entering the global race for a Herpes vaccine. Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines.\u00a0Continue reading &quot;Moderna Adds Herpes Vaccine Candidate to Pipeline&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/\" \/>\n<meta property=\"og:site_name\" content=\"Herpes Cure Advocacy\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100087212780212\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-18T13:28:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-18T14:03:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg\" \/>\n<meta name=\"author\" content=\"Patient Advocate\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@herpesadvocate\" \/>\n<meta name=\"twitter:site\" content=\"@herpesadvocate\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patient Advocate\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/\"},\"author\":{\"name\":\"Patient Advocate\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/person\\\/5a8a408f85fcdaa526d3173c93216d14\"},\"headline\":\"Moderna Adds Herpes Vaccine Candidate to Pipeline\",\"datePublished\":\"2022-02-18T13:28:34+00:00\",\"dateModified\":\"2022-02-18T14:03:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/\"},\"wordCount\":115,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/pexels-photo-2280547.jpeg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/\",\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/\",\"name\":\"Moderna Adds Herpes Vaccine Candidate to Pipeline - Herpes Cure Advocacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/pexels-photo-2280547.jpeg\",\"datePublished\":\"2022-02-18T13:28:34+00:00\",\"dateModified\":\"2022-02-18T14:03:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/pexels-photo-2280547.jpeg?fit=868%2C1300&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/pexels-photo-2280547.jpeg?fit=868%2C1300&ssl=1\",\"width\":868,\"height\":1300,\"caption\":\"Photo by Chokniti Khongchum on Pexels.com\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/2022\\\/02\\\/18\\\/moderna-adds-herpes-vaccine-candidate-to-pipeline\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/herpescureadvocacy.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Moderna Adds Herpes Vaccine Candidate to Pipeline\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#website\",\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/\",\"name\":\"Herpes Cure Advocacy\",\"description\":\"Advocating for a cure for Herpes Simplex Virus.\",\"publisher\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/herpescureadvocacy.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#organization\",\"name\":\"Herpes Cure Advocacy\",\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/HCA-main-logo.png?fit=450%2C110&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/herpescureadvocacy.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/HCA-main-logo.png?fit=450%2C110&ssl=1\",\"width\":450,\"height\":110,\"caption\":\"Herpes Cure Advocacy\"},\"image\":{\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=100087212780212\",\"https:\\\/\\\/x.com\\\/herpesadvocate\",\"https:\\\/\\\/www.instagram.com\\\/herpesadvocate\",\"https:\\\/\\\/www.reddit.com\\\/r\\\/HerpesCureAdvocates\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/herpes-cure-advocacy\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@herpes.advocate?lang=en\",\"https:\\\/\\\/themighty.com\\\/groups\\\/herpescureadvocacy\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/herpescureadvocacy.com\\\/#\\\/schema\\\/person\\\/5a8a408f85fcdaa526d3173c93216d14\",\"name\":\"Patient Advocate\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g\",\"caption\":\"Patient Advocate\"},\"sameAs\":[\"http:\\\/\\\/herpescureadvocacy.com\"],\"url\":\"https:\\\/\\\/herpescureadvocacy.com\\\/author\\\/herpescureadvocacy\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Moderna Adds Herpes Vaccine Candidate to Pipeline - Herpes Cure Advocacy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/","og_locale":"en_US","og_type":"article","og_title":"Moderna Adds Herpes Vaccine Candidate to Pipeline - Herpes Cure Advocacy","og_description":"Moderna is entering the global race for a Herpes vaccine. Moderna is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines.\u00a0Continue reading \"Moderna Adds Herpes Vaccine Candidate to Pipeline\"","og_url":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/","og_site_name":"Herpes Cure Advocacy","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100087212780212","article_published_time":"2022-02-18T13:28:34+00:00","article_modified_time":"2022-02-18T14:03:46+00:00","og_image":[{"url":"https:\/\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg","type":"","width":"","height":""}],"author":"Patient Advocate","twitter_card":"summary_large_image","twitter_creator":"@herpesadvocate","twitter_site":"@herpesadvocate","twitter_misc":{"Written by":"Patient Advocate","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#article","isPartOf":{"@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/"},"author":{"name":"Patient Advocate","@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/person\/5a8a408f85fcdaa526d3173c93216d14"},"headline":"Moderna Adds Herpes Vaccine Candidate to Pipeline","datePublished":"2022-02-18T13:28:34+00:00","dateModified":"2022-02-18T14:03:46+00:00","mainEntityOfPage":{"@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/"},"wordCount":115,"commentCount":1,"publisher":{"@id":"https:\/\/herpescureadvocacy.com\/#organization"},"image":{"@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#primaryimage"},"thumbnailUrl":"https:\/\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/","url":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/","name":"Moderna Adds Herpes Vaccine Candidate to Pipeline - Herpes Cure Advocacy","isPartOf":{"@id":"https:\/\/herpescureadvocacy.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#primaryimage"},"image":{"@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#primaryimage"},"thumbnailUrl":"https:\/\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg","datePublished":"2022-02-18T13:28:34+00:00","dateModified":"2022-02-18T14:03:46+00:00","breadcrumb":{"@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#primaryimage","url":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg?fit=868%2C1300&ssl=1","contentUrl":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/pexels-photo-2280547.jpeg?fit=868%2C1300&ssl=1","width":868,"height":1300,"caption":"Photo by Chokniti Khongchum on Pexels.com"},{"@type":"BreadcrumbList","@id":"https:\/\/herpescureadvocacy.com\/2022\/02\/18\/moderna-adds-herpes-vaccine-candidate-to-pipeline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/herpescureadvocacy.com\/"},{"@type":"ListItem","position":2,"name":"Moderna Adds Herpes Vaccine Candidate to Pipeline"}]},{"@type":"WebSite","@id":"https:\/\/herpescureadvocacy.com\/#website","url":"https:\/\/herpescureadvocacy.com\/","name":"Herpes Cure Advocacy","description":"Advocating for a cure for Herpes Simplex Virus.","publisher":{"@id":"https:\/\/herpescureadvocacy.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/herpescureadvocacy.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/herpescureadvocacy.com\/#organization","name":"Herpes Cure Advocacy","url":"https:\/\/herpescureadvocacy.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2026\/03\/HCA-main-logo.png?fit=450%2C110&ssl=1","contentUrl":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2026\/03\/HCA-main-logo.png?fit=450%2C110&ssl=1","width":450,"height":110,"caption":"Herpes Cure Advocacy"},"image":{"@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100087212780212","https:\/\/x.com\/herpesadvocate","https:\/\/www.instagram.com\/herpesadvocate","https:\/\/www.reddit.com\/r\/HerpesCureAdvocates\/","https:\/\/www.linkedin.com\/company\/herpes-cure-advocacy\/","https:\/\/www.tiktok.com\/@herpes.advocate?lang=en","https:\/\/themighty.com\/groups\/herpescureadvocacy\/"]},{"@type":"Person","@id":"https:\/\/herpescureadvocacy.com\/#\/schema\/person\/5a8a408f85fcdaa526d3173c93216d14","name":"Patient Advocate","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/05ebcf007475af5bc907f5c9cdd152a398b8131b81e5609a9fdde2882fc76cfd?s=96&d=identicon&r=g","caption":"Patient Advocate"},"sameAs":["http:\/\/herpescureadvocacy.com"],"url":"https:\/\/herpescureadvocacy.com\/author\/herpescureadvocacy\/"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/pcZX4e-di","jetpack-related-posts":[{"id":793,"url":"https:\/\/herpescureadvocacy.com\/2022\/02\/05\/harvey-friedman-provides-hope-for-hsv-at-univ-pennsylvania\/","url_meta":{"origin":824,"position":0},"title":"Harvey Friedman provides hope for an HSV Vaccine at the University of Pennsylvania","author":"Patient Advocate","date":"February 5, 2022","format":false,"excerpt":"Researchers, led by Dr. Harvey Friedman, from the Perelman School of Medicine at the University of Pennsylvania are close to clinical trials testing a vaccine protecting against genital herpes. Phase I trials for this HSV vaccine candidate, that will test prevention of genital herpes in humans, are expected to begin\u2026","rel":"","context":"With 1 comment","block_context":{"text":"With 1 comment","link":"https:\/\/herpescureadvocacy.com\/2022\/02\/05\/harvey-friedman-provides-hope-for-hsv-at-univ-pennsylvania\/#comments"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/screen-shot-2022-02-05-at-4.51.59-pm.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/screen-shot-2022-02-05-at-4.51.59-pm.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/screen-shot-2022-02-05-at-4.51.59-pm.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/screen-shot-2022-02-05-at-4.51.59-pm.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/screen-shot-2022-02-05-at-4.51.59-pm.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/02\/screen-shot-2022-02-05-at-4.51.59-pm.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1285,"url":"https:\/\/herpescureadvocacy.com\/2022\/06\/27\/new-clinical-trial-for-herpes-vaccine-from-biontech-upenn\/","url_meta":{"origin":824,"position":1},"title":"New Clinical Trial for Herpes Vaccine from Biontech + UPenn","author":"Patient Advocate","date":"June 27, 2022","format":false,"excerpt":"The BioNTech team and UPenn have previously partnered on pre-clinical study of an mRNA-based vaccine candidate to prevent genital herpes. This work is led by lead investigator Dr. Harvey Friedman and team at the University of Pennsylvania. A new clinical trial A Clinical Trial in Healthy Volunteers to Study the\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/06\/pexels-photo-3825529-2337376776-e1731468882205.jpeg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":1239,"url":"https:\/\/herpescureadvocacy.com\/2022\/05\/19\/new-clinical-trial-for-herpes-simplex-virus\/","url_meta":{"origin":824,"position":2},"title":"New Clinical Trial for Herpes Simplex Virus","author":"Patient Advocate","date":"May 19, 2022","format":false,"excerpt":"GlaxoSmithKline Pipeline UpdateGSK has officially updated its clinical research pipeline to include a vaccine for HSV-2! Their therapeutic vaccine for HSV-2 isn't mRNA (or what they called SAM technology) but an adjuvanted therapeutic vaccine. The trial (currently recruiting) is a Phase 1\/2 combined trial that ends in 2024. GSK will\u2026","rel":"","context":"With 2 comments","block_context":{"text":"With 2 comments","link":"https:\/\/herpescureadvocacy.com\/2022\/05\/19\/new-clinical-trial-for-herpes-simplex-virus\/#comments"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/05\/download.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":1861,"url":"https:\/\/herpescureadvocacy.com\/2022\/12\/30\/biontech-new-clinical-trial-for-herpes-vaccine-begins\/","url_meta":{"origin":824,"position":3},"title":"BioNTech New Clinical Trial for Herpes Vaccine begins","author":"Patient Advocate","date":"December 30, 2022","format":false,"excerpt":"December 21 2022, BioNTech announced they had dosed the first clinical trial participant. This is the first-in-human study aims to evaluate the safety and immunogenicity of prophylactic herpes virus vaccine candidate BNT163. Company statement; \u201cWe aim to help address diseases with a high unmet medical need and of global health\u2026","rel":"","context":"With 1 comment","block_context":{"text":"With 1 comment","link":"https:\/\/herpescureadvocacy.com\/2022\/12\/30\/biontech-new-clinical-trial-for-herpes-vaccine-begins\/#comments"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2022\/12\/pexels-photo-6804927.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":4528,"url":"https:\/\/herpescureadvocacy.com\/2024\/09\/12\/board-of-directors-statement-on-gsk-clinical-trial-news\/","url_meta":{"origin":824,"position":4},"title":"Board of Directors Statement on GSK Clinical Trial News","author":"Patient Advocate","date":"September 12, 2024","format":false,"excerpt":"For Immediate Release Media Contact: Email: info@herpescureadvocacy.com \u202aP: 267-797-7139\u202c Philadelphia, PA - Herpes Cure Advocacy has learned about the outcome of GSK\u2019s trial of GSK3943104\u00a0which has failed to meet the study\u2019s primary efficacy objective.\u00a0 As a result, this trial will not progress to Phase III studies. While we are disappointed\u2026","rel":"","context":"In &quot;Advocacy&quot;","block_context":{"text":"Advocacy","link":"https:\/\/herpescureadvocacy.com\/category\/advocacy\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2024\/09\/1726055045647-e1726155647587.jpg?fit=500%2C500&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":4139,"url":"https:\/\/herpescureadvocacy.com\/2024\/07\/24\/terri-warren-qa-recording\/","url_meta":{"origin":824,"position":5},"title":"Terri Warren Q&amp;A Recording","author":"Patient Advocate","date":"July 24, 2024","format":false,"excerpt":"We had a great turnout at our webinar last week featuring Terri Warren and her preliminary data from her Herpes survey. Thank you to everyone who joined and brought all of their questions! This webinar was recorded and is provided at the link below for anyone who was unable to\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/05\/Board-Head-shots.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/05\/Board-Head-shots.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/05\/Board-Head-shots.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/herpescureadvocacy.com\/wp-content\/uploads\/2023\/05\/Board-Head-shots.png?resize=700%2C400&ssl=1 2x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts\/824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/users\/205069572"}],"replies":[{"embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/comments?post=824"}],"version-history":[{"count":6,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts\/824\/revisions"}],"predecessor-version":[{"id":831,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/posts\/824\/revisions\/831"}],"wp:attachment":[{"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/media?parent=824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/categories?post=824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/herpescureadvocacy.com\/wp-json\/wp\/v2\/tags?post=824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}